谷歌浏览器插件
订阅小程序
在清言上使用

127P Atezolizumab (A) + Pertuzumab + Trastuzumab (PH) + Chemotherapy (CT) in HER2-positive Early Breast Cancer (HER2+ Ebc): Final Results of the Phase III IMpassion050 Trial

J. Huober,C.H. Barrios,N. Niikura,M. Jarzab, Y-C. Chang, S.L. Huggins-Puhalla, J.L. Pedrini,L. Zhukova, M. Curran,D. Eiger, V. Craine,C. Lambertini,E. Restuccia, H. Zhang

ESMO Open(2024)

引用 0|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要